RNR Stock Analysis: Renaissancere Holdings | NYSE
Insurance - Reinsurance | NYSE, USA | Market Cap: 13.818m USD | 12M Return: 34.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 108M
EPS Trend: 31.7%
Qual. Beats: -1
Rev. Trend: 85.3%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
RenaissanceRe Holdings Ltd. (RNR) is a Bermuda-based global provider of reinsurance and insurance products, operating through two core segments: Property and Casualty and Specialty. The Property segment focuses on catastrophe excess of loss reinsurance, covering events such as hurricanes, earthquakes, typhoons, and terrorism, while also offering proportional reinsurance and specialty binding facilities. The Casualty and Specialty segment provides a broad portfolio including directors and officers liability, medical malpractice, professional indemnity, cyber, and political risk coverage. Products are distributed primarily through intermediaries, and the company also invests and manages its own investment funds.
Founded in 1993 and headquartered in Pembroke, Bermuda, the company has been publicly traded since its 1995 IPO on the NYSE. As a large-cap player in the reinsurance sector, RNR benefits from Bermudas long-standing position as a leading hub for global reinsurance and insurance underwriting, offering favorable regulatory and tax conditions for risk-bearing businesses.
- Hard reinsurance market lifts premium rates at key renewals
- Major catastrophe losses pressure Property segment underwriting results
- Casualty and Specialty segment expansion diversifies earnings mix
- Higher net investment income from rising rates boosts consolidated margins
| Net Income: 2.81b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 3.44 > 1.0 |
| NWC/Revenue: 307.7% < 20% (prev 272.6%; Δ 35.05% < -1%) |
| CFO/TA 0.08 > 3% & CFO 4.22b > Net Income 2.81b |
| Net Debt (-11.5b) to EBITDA (4.76b): -2.42 < 3 |
| Current Ratio: 4.52 > 1.5 & < 3 |
| Outstanding Shares: last quarter (42.6m) vs 12m ago -16.59% < -2% |
| Gross Margin: 55.03% > 18% (prev 23.53%; Δ 31.50% > 0.5%) |
| Asset Turnover: 21.37% > 50% (prev 23.34%; Δ -1.97% > 0%) |
| Interest Coverage Ratio: 37.91 > 6 (EBIT TTM 4.76b / Interest Expense TTM 125.6m) |
| A: 0.66 (Total Current Assets 45.3b - Total Current Liabilities 10.0b) / Total Assets 53.7b |
| B: 0.20 (Retained Earnings 10.7b / Total Assets 53.7b) |
| C: 0.09 (EBIT TTM 4.76b / Avg Total Assets 53.7b) |
| D: 0.33 (Book Value of Equity 11.5b / Total Liabilities 35.2b) |
| Altman-Z'' = 5.90 = AAA |
| DSRI: 1.00 (Receivables 12.2b/13.4b, Revenue 11.5b/12.5b) |
| GMI: 0.43 (GM 23.53% / 55.03%) |
| AQI: 0.93 (AQ_t 0.15 / AQ_t-1 0.17) |
| SGI: 0.92 (Revenue 11.5b / 12.5b) |
| TATA: -0.03 (NI 2.81b - CFO 4.22b) / TA 53.7b) |
| Beneish M = -3.65 (Cap -4..+1) = AAA |
As of July 09, 2026, the stock is trading at USD 322.37 with a total of 249,101 shares traded. Over the past week, the price has changed by +1.73%, over one month by +14.43%, over three months by +5.12% and over the past year by +34.76%.
Current recommended Stop Loss: 304.10 (which is 5.7% or 2.3 ATR below the current price).
Renaissancere Holdings has received a consensus analysts rating of 3.42. Therefore, it is recommended to hold RNR.
- StrongBuy: 2
- Buy: 4
- Hold: 4
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 327.3 | 1.5% |
P/E Trailing = 5.4638
P/E Forward = 9.0662
P/S = 1.1925
P/B = 1.2923
P/EG = 3.6212
Revenue TTM = 11.5b USD
EBIT TTM = 4.76b USD
EBITDA TTM = 4.76b USD
Long Term Debt = 2.33b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 2.33b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -11.5b USD (calculated: Debt 2.33b - CCE 13.8b)
Enterprise Value = 2.30b USD (13.8b + Debt 2.33b - CCE 13.8b)
Interest Coverage Ratio = 37.91 (Ebit TTM 4.76b / Interest Expense TTM 125.6m)
EV/FCF = 0.55x (Enterprise Value 2.30b / FCF TTM 4.18b)
FCF Yield = 181.6% (FCF TTM 4.18b / Enterprise Value 2.30b)
FCF Margin = 36.46% (FCF TTM 4.18b / Revenue TTM 11.5b)
Net Margin = 24.46% (Net Income TTM 2.81b / Revenue TTM 11.5b)
Gross Margin = 55.03% ((Revenue TTM 11.5b - Cost of Revenue TTM 5.16b) / Revenue TTM)
Gross Margin QoQ = 54.75% (prev 67.47%)
Tobins Q-Ratio = 0.04 (Enterprise Value 2.30b / Total Assets 53.7b)
Interest Expense / Debt = 5.39% (Interest Expense 125.6m / Debt 2.33b)
Taxrate = 10.25% (474.8m / 4.63b)
NOPAT = 4.27b (EBIT 4.76b * (1 - 10.25%))
Current Ratio = 3.53 (Total Current Assets 45.3b / Total Current Liabilities 12.8b)
Debt / Equity = 0.20 (Debt 2.33b / totalStockholderEquity, last quarter 11.5b)
Debt / EBITDA = -2.42 (Net Debt -11.5b / EBITDA 4.76b)
Debt / FCF = -2.75 (Net Debt -11.5b / FCF TTM 4.18b)
Total Stockholder Equity = 11.4b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.23% (Net Income 2.81b / Total Assets 53.7b)
RoE = 24.71% (Net Income TTM 2.81b / Total Stockholder Equity 11.4b)
RoCE = 34.77% (EBIT 4.76b / Capital Employed (Equity 11.4b + L.T.Debt 2.33b))
RoIC = 9.90% (NOPAT 4.27b / Invested Capital 43.1b)
WACC = 6.25% (E(13.8b)/V(16.1b) * Re(6.49%) + D(2.33b)/V(16.1b) * Rd(5.39%) * (1-Tc(0.10)))
Discount Rate = 6.49% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -76.41 | Cagr: -7.72%
[DCF] Terminal Value 77.97% ; FCFF base≈3.44b ; Y1≈3.95b ; Y5≈5.81b
[DCF] Fair Price = 2.32k (EV 87.4b - Net Debt -11.5b = Equity 98.9b / Shares 42.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 31.74 | EPS CAGR: 15.87% | SUE: -0.96 | # QB: -1
Revenue Correlation: 85.35 | Revenue CAGR: 20.31% | SUE: -0.73 | # QB: 0
EPS current Quarter (2026-06-30): EPS=11.02 | Chg30d=+0.83% | Revisions=+40% | Analysts=16
EPS next Quarter (2026-09-30): EPS=6.26 | Chg30d=+0.86% | Revisions=+25% | Analysts=4
EPS current Year (2026-12-31): EPS=40.82 | Chg30d=+0.21% | Revisions=+40% | GrowthEPS=+4.4% | GrowthRev=-10.2%
EPS next Year (2027-12-31): EPS=40.47 | Chg30d=-0.55% | Revisions=+0% | GrowthEPS=+26.4% | GrowthRev=+1.4%
[Analyst] Revisions Ratio: +50% (up=6, down=1)